Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TENKU

TenX Keane Acquisition (TENKU)

TenX Keane Acquisition
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TENKU
DateTimeSourceHeadlineSymbolCompany
05/21/20242:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
05/20/20244:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
05/15/20243:24PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TENKUTenX Keane Acquisition
01/30/20244:25PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TENKUTenX Keane Acquisition
01/18/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
01/10/20243:42PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
01/10/20242:21PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TENKUTenX Keane Acquisition
01/10/20241:29PMGlobeNewswire Inc.TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment ProposalNASDAQ:TENKUTenX Keane Acquisition
01/08/20243:46PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TENKUTenX Keane Acquisition
12/28/202311:39AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TENKUTenX Keane Acquisition
11/20/20234:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
10/24/20236:42AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TENKUTenX Keane Acquisition
10/24/20236:41AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
10/24/20236:30AMPR Newswire (US)Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKUTenX Keane Acquisition
10/24/20236:30AMGlobeNewswire Inc.Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKUTenX Keane Acquisition
10/18/20234:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
10/18/20233:00PMGlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKUTenX Keane Acquisition
08/16/20231:44PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
07/18/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
07/18/20233:00PMGlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKUTenX Keane Acquisition
05/15/20233:32PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TENKUTenX Keane Acquisition
03/31/20233:33PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TENKUTenX Keane Acquisition
02/14/20232:33PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
02/10/20233:40PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TENKUTenX Keane Acquisition
02/08/20237:40AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
02/08/20235:04AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
12/06/20224:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TENKUTenX Keane Acquisition
12/06/20223:58PMGlobeNewswire Inc.TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022NASDAQ:TENKUTenX Keane Acquisition
10/24/20224:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TENKUTenX Keane Acquisition
10/18/20221:20PMGlobeNewswire Inc.TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment OptionNASDAQ:TENKUTenX Keane Acquisition
 Showing the most relevant articles for your search:NASDAQ:TENKU